In a prospective study conducted in Germany [17] of 111 patients with PTCL (excluding ALK + ALCL), 75 patients achieved either CR or PR after 4–6 cycles of CHOP and ASCT. Here, ALK is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.